Share on StockTwits
 

Novartis (NYSE:NVS) declared a annual dividend on Tuesday, February 4th, AnalystRatings.NET reports. Shareholders of record on Monday, March 3rd will be given a dividend of 2.7186 per share on Tuesday, March 11th. This represents a yield of 3.48%. The ex-dividend date of this dividend is Thursday, February 27th.

A number of analysts have recently weighed in on NVS shares. Analysts at UBS AG initiated coverage on shares of Novartis in a research note to investors on Thursday, January 9th. They set a “buy” rating on the stock. On a related note, analysts at Jefferies Group downgraded shares of Novartis from a “buy” rating to a “hold” rating in a research note to investors on Thursday, January 9th. Finally, analysts at Natixis upgraded shares of Novartis from a “neutral” rating to a “buy” rating in a research note to investors on Monday, November 25th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have assigned a buy rating to the company’s stock. Novartis currently has a consensus rating of “Hold” and an average price target of $82.33.

Shares of Novartis (NYSE:NVS) traded down 0.73% during mid-day trading on Tuesday, hitting $78.046. 1,507,254 shares of the company’s stock traded hands. Novartis has a 52-week low of $66.65 and a 52-week high of $82.02. The stock’s 50-day moving average is $79.66 and its 200-day moving average is $76.7. The company has a market cap of $190.8 billion and a P/E ratio of 21.25.

Novartis (NYSE:NVS) last issued its quarterly earnings data on Wednesday, January 29th. The company reported $1.20 earnings per share for the quarter, missing the analysts’ consensus estimate of $1.27 by $0.07. The company had revenue of $15.08 billion for the quarter, compared to the consensus estimate of $15.16 billion. During the same quarter last year, the company posted $1.27 earnings per share. Novartis’s revenue was up 1.7% compared to the same quarter last year. On average, analysts predict that Novartis will post $5.48 earnings per share for the current fiscal year.

Novartis AG is a Switzerland-based holding that, through its subsidiaries, is engaged in the research, development, manufacture and marketing of healthcare products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.